We are pleased to announce our first live & on-demand webinar series “Gelatin-based Extracellular Matrices for 3D Cell Culture & Bioprinting”! 

We are excited to welcome Associate Professor Daniela Loessner and Dr Nathalie Bock as speakers in our first webinar. Daniela and Nathalie are both exceptional scientists who have been instrumental in establishing tissue-engineered 3D models of the cancer microenvironment using photocrosslinkable extracellular matrices.

Our goal is to bring people from different research fields together and provide an overview of the vast applications of gelatin-based extracellular matrices in cell culture and tissue engineering applications.

About The Speakers

Associate Professor Daniela Loessner

Leader - 3D Cancer Models Lab
Monash University

Daniela has a joint appointment across the Faculties of Engineering and Medicine, Nursing & Health Sciences at Monash University. She holds a PhD in Natural Sciences (Dr rer nat) from the Faculty of Chemistry, Technical University of Munich, Germany and has over 17 years of academic experience, working as a research scientist and group leader in Australia, Europe and USA. Daniela’s research focuses on the role of the extracellular microenvironment in cancer progression and therapy response. Her multidisciplinary team has been instrumental in the establishment of gelatin-based extracellular matrices replicating the biological and biomechanical characteristics of the tumour microenvironment. 

Dr. Nathalie Bock

Leader - Bioengineered 3D Models
Queensland University of Technology

Nathalie is leading the “Bioengineered 3D Models” group at the Queensland University of Technology. Her group’s research focuses on developing biomimetic 3D cell culture model systems using advanced biomaterials and tissue engineering technologies to study bone and cancer biology and bone metastases. Some of the goals of the research includes the development of in vitro preclinical models for personalised drug testing in advanced prostate and breast cancer and recapitulating the human bone microenvironment in vitro and in vivo. Some recent work successfully developed a human primary in vitro 3D model of osteoblastic mineralized tissue, which partly recapitulates key bone signalling and functions. Dr Bock has expertise in controlled drug delivery, bioprinting, hydrogels and fibre-based scaffolds, bone tissue engineering, organoid models and 4D imaging.

Gelomics Live Webinar 2020
Dec 10, 10:00 AM – 10:40 AM GMT+10
Via Online Invitation Link

© Gelomics Pty Ltd, Brisbane, Australia 

All rights reserved.

For Research Use Only. 

Not for use in diagnostic procedures.


Gelomics Pty Ltd

ABN: 14 624 623 623

1800 865 060


60 Musk Avenue

Kelvin Grove, QLD 4059

And win a LunaCrosslinker
valued at $3,490